March 6, 2025 New Biomarkers Could Improve Early Detection, Monitoring of Kidney Injury C-Path and Boston Medical Center published results for six biomarkers that could improve the early and accurate detection...
March 6, 2025 C-Path Announces Steven W. Spector and James A. King as New Board Members C-Path announced the appointments of Steven W. Spector and James A. King to its Board of Directors...
February 28, 2025 Ultra Rare: A Mission to Discover the Cause Behind a Young Boy’s Developmental Delays Kelly Carwile, mother to Reed and sister of C-Path Director Mike Minchik, has been on a mission to discover the cause behind her..
February 26, 2025 Transforming Data into Breakthroughs: 5 Years of RDCA-DAP Journey and Impact In honor of Rare Disease Month, Alexandre Bétourné took some time to sit down and discuss the impact RDCA-DAP has made...
January 14, 2025 Addressing the need for Standardization of Symptomatic Medication Documentation in Parkinson’s Disease Clinical Research: A Call to Action People with Parkinson's disease (PD) are prescribed a variety of medications to mitigate symptoms and improve their quality...
February 25, 2025 A Framework to Standardize Gait Study Protocols in Parkinson’s Disease Research over the past twenty years has shown that gait outcomes have a high sensitivity for diagnosing Parkinson's disease (PD)..
February 1, 2025 Understanding what aspects of Parkinson’s disease matter most to patients and families Understanding what matters to people with Parkinson’s and their family is essential to derive relevant clinical outcome measures
February 1, 2025 Accelerating Parkinson’s Disease Drug Development with Federated Learning Approaches Parkinson’s Disease is a progressive neurodegenerative disorder afflicting almost 12 million people...
February 24, 2025 Lysosomal Storage Disease Data Sharing Workshop, Webinar Series – Session #1: Setting the Scene C-Path's CPLD team presents, "Lysosomal Storage Disease Data Sharing Workshop, Webinar Series - Session #1...
February 19, 2025 Advancing Neonatal Drug Development Through Collaboration At C-Path’s INC, we believe that meaningful progress in neonatal drug development...